MENU
Aim higher

MetVision

Novel c-Met Protein Targeted Molecular Imaging of Cancer with the SurgVision Endoscope Explorer

MetVision is a low cost cancer diagnosis and surgical guidance solution that combines the novel EMI-137 biomarker and the SurgVision Endoscope Explorer (SVEE) detection hardware and control software. This advanced optical imaging solution will address the unmet healthcare need for regulatory approved tumour specific fluorescent imaging agents and supporting fluorescent imaging endoscopes, dramatically improving the imaging of precancerous and cancerous lesions and tissue.
Project ID: 
11 463
Ranking: 
18
Cut-off: 
7
Start date: 
01-09-2017
Project Duration: 
24months
Project costs: 
1 269 040.00€
Technological Area: 
Surgery
Market Area: 
Other